A physician's guide to the 2-dose schedule of MenB-FHbp vaccine
Meningococcal serogroup B (MenB) is the predominant cause of invasive meningococcal disease in the United States, with older adolescents and young adults attending college at increased risk. Notably, MenB caused all meningococcal disease outbreaks at US colleges between 2011 and 2018. MenB disease i...
Saved in:
Main Authors: | Angee McDaniel (Author), Amanda Dempsey (Author), Amit Srivastava (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine
by: John L. Perez, et al.
Published: (2018) -
Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018-2020
by: Pasquale Stefanizzi, et al.
Published: (2022) -
Increasing awareness and uptake of the MenB vaccine on a large university campus
by: Eric Richardson, et al.
Published: (2021) -
Introduction of a second MenB vaccine into Europe - needs and opportunities for public health
by: Jamie Findlow, et al.
Published: (2019) -
Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
by: Jessica Presa, et al.
Published: (2023)